Literature DB >> 32602252

Prevalence, risk factors and impact of posterior staphyloma diagnosed from wide-field optical coherence tomography in Singapore adults with high myopia.

Feihui Zheng1,2, Chee-Wai Wong1,2,3, Charumathi Sabanayagam1,2,3, Yin-Bun Cheung3, Saiko Matsumura1,2, Jacqueline Chua1,2,3, Ryan Eyn Kidd Man1,2,3, Kyoko Ohno-Matsui4, Tien-Yin Wong1,2,3, Ching-Yu Cheng1,2,3,5, E Shyong Tai5, Ecosse Luc Edouard Denis Lamoureux1,2,3, Leopold Schmetterer1,2,3, Anthony Kuo6, Quan V Hoang1,2,3,7, Seang-Mei Saw1,2,3,5.   

Abstract

PURPOSE: To investigate the prevalence and risk factors of posterior staphyloma using wide-field optical coherence tomography (WF-OCT) in adults with high myopia in Singapore.
DESIGN: Population-based cross-sectional study.
METHODS: Adults with spherical equivalent (SE) ≤ -5D in either eye at the first visit of Singapore Epidemiology of Eye Diseases study and Singapore Prospective Study Program study were recruited. Posterior staphyloma was diagnosed using WF-OCT (PLEX® Elite9000, Carl Zeiss Meditec). Myopic macular degeneration (MMD), myopic traction maculopathy (MTM) and vision-related quality of life (VRQoL) were assessed using fundus photographs, DRI-Triton OCT (Topcon) and the Impact of Vision Impairment (IVI) questionnaire, respectively. Factors associated with posterior staphyloma were identified with multilevel, multivariable logistic regression. Impact of posterior staphyloma on MMD, MTM and visual function was analysed with multilevel, multivariable logistic regression and linear mixed model, respectively.
RESULTS: Among the 225 eyes [mean SE = -6.5 ± 2.2 D, mean axial length (AL) = 26.2 ± 1.5 mm] of 117 participants (mean age = 60.3 ± 7.1 years), posterior staphyloma was detected in 47 (20.9%) eyes of 38 (32.5%) participants. Older age [odds ratio (OR), 1.18; 95% confidence interval (CI), 1.10-1.26], more myopic SE (0.63; 0.51-0.77) and increased AL (2.51; 1.69-3.73) were associated with higher prevalence of posterior staphyloma (all p < 0.001). Adults with posterior staphyloma had higher odds of MMD (2.67; 1.23-5.82; p = 0.013), MTM (3.79; 1.13-12.68; p = 0.031) and worse IVI Reading (β = -1.44; -2.31 to 0.58; p = 0.001) scores.
CONCLUSIONS: About one in three adults with high myopia had posterior staphyloma, which was associated with increased odds of having myopic maculopathy and a detrimental impact on VRQoL.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  high myopia; myopic maculopathy; posterior staphyloma; wide-field optical coherence tomography

Year:  2020        PMID: 32602252     DOI: 10.1111/aos.14527

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  10 in total

1.  Observation of macular hole associated with retinoschisis in patients with high myopia.

Authors:  Ke Zhang; Xiaohan Yang; Zengyi Wang; Yanping Yu; Yajie Yu; Lingzi Liu; Biying Qi; Xijin Wu; Wu Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-22       Impact factor: 3.535

Review 2.  Advances in OCT Imaging in Myopia and Pathologic Myopia.

Authors:  Yong Li; Feihui Zheng; Li Lian Foo; Qiu Ying Wong; Daniel Ting; Quan V Hoang; Rachel Chong; Marcus Ang; Chee Wai Wong
Journal:  Diagnostics (Basel)       Date:  2022-06-08

Review 3.  Myopic Traction Maculopathy: Diagnostic and Management Strategies.

Authors:  Rino Frisina; Irene Gius; Michele Palmieri; Alessandro Finzi; Luigi Tozzi; Barbara Parolini
Journal:  Clin Ophthalmol       Date:  2020-11-02

4.  Ultrawide field, distortion-corrected ocular shape estimation with MHz optical coherence tomography (OCT).

Authors:  Bingyao Tan; Ryan P McNabb; Feihui Zheng; Yin Ci Sim; Xinwen Yao; Jacqueline Chua; Marcus Ang; Quan V Hoang; Anthony N Kuo; Leopold Schmetterer
Journal:  Biomed Opt Express       Date:  2021-08-23       Impact factor: 3.732

Review 5.  IMI 2021 Yearly Digest.

Authors:  Monica Jong; Jost B Jonas; James S Wolffsohn; David A Berntsen; Pauline Cho; Danielle Clarkson-Townsend; Daniel I Flitcroft; Kate L Gifford; Annechien E G Haarman; Machelle T Pardue; Kathryn Richdale; Padmaja Sankaridurg; Milly S Tedja; Christine F Wildsoet; Joan E Bailey-Wilson; Jeremy A Guggenheim; Christopher J Hammond; Jaakko Kaprio; Stuart MacGregor; David A Mackey; Anthony M Musolf; Caroline C W Klaver; Virginie J M Verhoeven; Veronique Vitart; Earl L Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-28       Impact factor: 4.799

6.  RNA-Seq Analysis Reveals an Essential Role of the Tyrosine Metabolic Pathway and Inflammation in Myopia-Induced Retinal Degeneration in Guinea Pigs.

Authors:  Ling Zeng; Xiaoning Li; Jian Liu; Hong Liu; Heping Xu; Zhikuan Yang
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

7.  Association Between Types of Posterior Staphyloma and Refractive Error After Cataract Surgery for High Myopia.

Authors:  Jing Wu; Ruochen Wang; Can Liu; Yu Zhou; Ziyuan Jiang; Fang Liu
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

8.  Progression Patterns of Myopic Traction Maculopathy in the Fellow Eye After Pars Plana Vitrectomy of the Primary Eye.

Authors:  Kangjie Kong; Sisi Xu; Yingchao Wang; Yuhe Qi; Qing Chang; Rui Jiang; Chunhui Jiang; Xin Huang; Dekang Gan; Yanqiong Zhang; Ling Chen; Ling Wang; Xiaogang Luo; Yaowu Qin; Haixiang Wu; Min Zhou; Yingqin Ni; Gezhi Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

9.  Editorial: Advances in Management and Treatment of High Myopia and Its Complications.

Authors:  Quan V Hoang; Xavier Chan; Xiangjia Zhu; Xiangtian Zhou; Xiangchao Shentu; Yi Lu
Journal:  Front Med (Lausanne)       Date:  2022-03-10

10.  Association of Aberrant Posterior Vitreous Detachment and Pathologic Tractional Forces With Myopic Macular Degeneration.

Authors:  Kai Yuan Tey; Qiu Ying Wong; Yee Shan Dan; Andrew S H Tsai; Daniel S W Ting; Marcus Ang; Gemmy Chiu Ming Cheung; Shu Yen Lee; Tien Yin Wong; Quan V Hoang; Chee Wai Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.